← Every firm
Adamis Pharmaceuticals Corporation FDA Recalls
2 recalls on file across drugs, 2 of them Class I and 0 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Class IMar 21, 2022Defective Delivery System: Potential clogging of the needle |
| SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, MClass IMar 21, 2022Defective Delivery System: Potential clogging of the needle |